|
FEATURING PRECONFERENCES
|
- Precon I: Compliance 101
- Precon II: Auditing and Monitoring Boot Camp
- Precon III: A Comprehensive Overview of Pharma and Medical Device Corporate Integrity Agreements (CIAs)
- Precon IV: The New Era of Scrutiny: FCPA Compliance in Pharma Operations
|
|
|
PLENARY SESSIONS
|
- OIG Update
- DOJ Criminal Division Update
- Prosecuting Pharma and Device Fraud
- FDA-DDMAC Update
- AUSA Panel
- Qui Tam Panel
- State Enforcement Panel
- Best Practices in Negotiating and Implementing CIAs
- State Disclosure, Federal Sunshine Act and Global Transparency
- Life Sciences in America the Morning after the Election
- Managing Internal and External Investigations
- PhRMA’s New Compliance Work Group Update
- Global Pharma and Device Compliance Issues and Strategies
|
|
|
AND MINI SUMMITS:
|
- Mini Summit I: Co-pay Coupon Litigation Update
- Mini Summit II: What Enhanced Obligations in CIAs and DPAs say about Agency Expectations for Compliance Programs
- Mini Summit III: Compliance Issues in Global R&D and Medical Affairs
- Mini Summit IV: US Disclosure Implementation Update
- Mini Summit V: Medical Device Compliance Issues Update
- Mini Summit VI: Global Pharma and Device Compliance Issues
- Mini Summit VII: Anticorruption, Including FCPA and UK Bribery Act Update
- Mini Summit VIII: Fair Market Value Update
- Mini Summit IX: Enforcement Threat Against Individuals
- Mini Summit X: Global Transparency Update
- Mini Summit XI: Special Compliance Issues and of Small Pharma and Medical Device Companies
- Mini Summit XII: Integrating a Culture of Ethics into Your Compliance Program
- Mini Summit XIII: Government Price Reporting Update
- Mini Summit XIV: Clinical Trial Disclosure and Results Reporting Liability under FDAAA, Section 801
- Mini Summit XV: Board and Management Certifications and Working with an IRO
- Mini Summit XVI: Drug Samples Disclosure: The Next Horizon?
- Mini Summit XVII: Professional Responsibilities for Compliance Officers and In-house Counsel in the Pharmaceutical, Biotech and Medical Device Industries
- Mini Summit XVIII: Compliance Program Innovation
|
|
|
Who Should Attend
|
- Pharmaceutical and Health Care Executives and Board Members
- Compliance Executives
- Health Plan, Health System and Physician Organizations
- Medical Directors
- Physicians
- Pharmacists and Pharmacy Technicians
- Purchasers, including Private Employers and Public Purchasers
- Pharmaceutical Manufacturers
- Generic Pharmaceutical Manufacturers
- Site Management Organizations
- Clinical Research Organizations
- Pharmacy Benefit Management Companies
|
- Nurses
- Health Plans and Health Insurers
- Wholesale, Retail, Mail Order and Internet Pharmacies
- Health Care Attorneys and In-house Counsel
- Compliance Officers
- Privacy Officers
- Ethics Officers
- Food and Drug Law Attorneys
- Pharmaceutical Consultants
- Investment Bankers
- Venture Capitalists
- Health Care Regulators and Policy Makers
- Health Services Researchers and Academics
- Auditors
|
About the Pharmaceutical Compliance Forum
|
|
The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs. The members meet twice a year, for two days, focusing on open and informal sharing of compliance information, best practices, and current developments in the field, and sponsors a three-day compliance congress each Fall. For membership information, contact Tim Bower at 215-599-6617 or via email at info@PharmaComplianceForum.org. Please visit their website at www.PharmaComplianceForum.org.
|
|
|
